Brain Tumor Reports

Volume 20 Number 10
October 2018


Home > Publications > Brain Tumor Reports > Volume 20, Year 2018 > Number 10, October



CONTENTS



GLIOMAS
BRAIN STEM GLIOMAS
Diffuse intrinsic pontine gliomas
HIGH-GRADE GLIOMAS
Gliomatosis cerebri
LOW-GRADE GLIOMAS
DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS
GLIOBLASTOMA
EMBRYONAL TUMORS
LYMPHOMAS
METASTATIC TUMORS





GLIOMAS

.

Sadik ZHA, Hanssens PEJ, Verheul JB, Beute GN, Te Lie S, Leenstra S, Ardon H.
Gamma knife radiosurgery for recurrent gliomas.
J Neurooncol. 2018 Sep 6. doi: 10.1007/s11060-018-2988-0. [Epub ahead of print]
Source | Full text | Similar articles



.

van den Bent MJ, Klein M, Smits M, Reijneveld JC, French PJ, Clement P, de Vos FYF, Wick A, Mulholland PJ, Taphoorn MJB, Lewis J, Weller M, Chinot OL, Kros JM, de Heer I, Verschuere T, Coens C, Golfinopoulos V, Gorlia T, Idbaih A.
Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial.
Lancet Oncol. 2018 Aug 13. pii: S1470-2045(18)30362-0. doi: 10.1016/S1470-2045(18)30362-0. [Epub ahead of print]
Source | Full text | Similar articles



.

Wood H.
Addition of bevacizumab fails to improve on temozolomide alone for glioma therapy.
Nat Rev Neurol. 2018 Aug 29. doi: 10.1038/s41582-018-0067-y. [Epub ahead of print]
Comment on: Van den Bent MJ et al.,Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial. [Lancet Oncol. 2018 Aug 13].
Source | Full text | Similar articles



BRAIN STEM GLIOMAS




Diffuse intrinsic pontine gliomas


.

Maxwell R, Luksik AS, Garzon-Muvdi T, Yang W, Huang J, Bettegowda C, Jallo GI, Terezakis SA, Groves M.
Population-based Study Determining Predictors of Cancer-Specific Mortality and Survival in Pediatric High-grade Brainstem Glioma.
World Neurosurg. 2018 Aug 20. pii: S1878-8750(18)31827-8. doi: 10.1016/j.wneu.2018.08.044. [Epub ahead of print]
Source | Abstract | Similar articles



.

von Bueren AO, Karremann M, Gielen GH, Benesch M, Fouladi M, van Vuurden DG, van Zanten SEMV, Hoffman LM, Kramm CM.
A suggestion to introduce the diagnosis of "diffuse midline glioma of the pons, H3 K27 wildtype (WHO grade IV)".
Acta Neuropathol. 2018 Jul;136(1):171-173. doi: 10.1007/s00401-018-1863-6. Epub 2018 May 21. Erratum in: Acta Neuropathol. 2018 Aug 16.
Source | Full text | Similar articles



HIGH-GRADE GLIOMAS




Gliomatosis cerebri


.

Georgakis MK, Tsivgoulis G, Spinos D, Dimitriou NG, Kyritsis AP, Herrlinger U, Petridou ET.
Clinical, neuroimaging and histopathological features of gliomatosis cerebri: a systematic review based on synthesis of published individual patient data.
J Neurooncol. 2018 Aug 16. doi: 10.1007/s11060-018-2976-4. [Epub ahead of print]
Source | Full text | Similar articles



LOW-GRADE GLIOMAS


.

Duffau H.
Diffuse low-grade glioma, oncological outcome and quality of life: a surgical perspective.
Curr Opin Oncol. 2018 Aug 18. doi: 10.1097/CCO.0000000000000483. [Epub ahead of print]
Source | Full text | Similar articles



.

Yang K, Nath S, Koziarz A, Badhiwala JH, Ghayur H, Sourour M, Catana D, Nassiri F, Alotaibi MB, Kameda-Smith M, Manoranjan B, Aref MH, Mansouri A, Singh S, Almenawer SA.
Biopsy Versus Subtotal Versus Gross Total Resection in Patients With Low-Grade Glioma: A Systematic Review and Meta-Analysis.
World Neurosurg. 2018 Aug 30. pii: S1878-8750(18)31946-6. doi: 10.1016/j.wneu.2018.08.163. [Epub ahead of print]
Source | Abstract | Similar articles



DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS

.

Cohen KJ, Constine LS, Marcus KJ, Packer RJ, Smith MA.
Childhood Astrocytomas Treatment (PDQ®): Health Professional Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2018 Aug 17.
Source | Table of contents | Book | Similar articles



GLIOBLASTOMA


.

Das M.
Iniparib improves survival in newly diagnosed glioblastoma.
Lancet Oncol. 2018 Aug 31. pii: S1470-2045(18)30665-X. doi: 10.1016/S1470-2045(18)30665-X. [Epub ahead of print]
Comment on: Blakeley JO et al., Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma. (Clin Cancer Res. 2018 Aug 21)
Source | Full text | Similar articles



.

Blakeley JO, Grossman SA, Chi AS, Mikkelsen T, Rosenfeld MR, Ahluwalia MS, Nabors LB, Eichler A, Garcia-Ribas I, Desideri S, Ye X.
Phase II Study of Iniparib with Concurrent Chemoradiation in Patients with Newly Diagnosed Glioblastoma.
Clin Cancer Res. 2018 Aug 21. pii: clincanres.0110.2018. doi: 10.1158/1078-0432.CCR-18-0110. [Epub ahead of print]
Source | Full text | Similar articles



.

Bota DA, Chung J, Dandekar M, Carrillo JA, Kong XT, Fu BD, Hsu FP, Schönthal AH, Hofman FM, Chen TC, Zidovetzki R, Pretto C, Strik A, Schijns VE, Stathopoulos A.
Phase II study of ERC1671 plus bevacizumab versus bevacizumab plus placebo in recurrent glioblastoma: interim results and correlations with CD4+ T-lymphocyte counts.
CNS Oncol. 2018 Aug 29. doi: 10.2217/cns-2018-0009. [Epub ahead of print]
Source | Full text | Similar articles



.

Erices JI, Torres Á, Niechi I, Bernales I, Quezada C.
Current natural therapies in the treatment against glioblastoma.
Phytother Res. 2018 Aug 15. doi: 10.1002/ptr.6170. [Epub ahead of print]
Source | Full text | Similar articles



.

Guzauskas GF, Salzberg M, Wang BC.
Estimated lifetime survival benefit of tumor treating fields and temozolomide for newly diagnosed glioblastoma patients.
CNS Oncol. 2018 Aug 20. doi: 10.2217/cns-2018-0010. [Epub ahead of print]
Source | Full text | Similar articles



.

Hao J, Godley A, Shoemake JD, Han Z, Magnelli A, Yu JS.
The effects of extra high dose rate irradiation on glioma stem-like cells.
PLoS One. 2018 Aug 17;13(8):e0202533. doi: 10.1371/journal.pone.0202533. eCollection 2018.
Source | Full text | Similar articles



.

Jovčevska I.
Genetic secrets of long-term glioblastoma survivors.
Bosn J Basic Med Sci. 2018 Aug 14. doi: 10.17305/bjbms.2018.3717. [Epub ahead of print]
Source | Full text | Similar articles



.

Karpel-Massler G, Siegelin MD.
TIC10/ONC201-a potential therapeutic in glioblastoma.
Transl Cancer Res. 2017 Dec;6(Suppl 9):S1439-S1440. doi: 10.21037/tcr.2017.10.51.
Comment on: Arrillaga-Romany I, Chi AS, Allen JE, et al. A phase 2 study of the first imipridone ONC201, a selective DRD2 antagonist for oncology, administered every three weeks in recurrent glioblastoma. Oncotarget 2017;8:79298-304
Source | Full text | Similar articles



.

Li K, Lu D, Guo Y, Wang C, Liu X, Liu Y, Liu D.
Trends and patterns of incidence of diffuse glioma in adults in the United States, 1973-2014.
Cancer Med. 2018 Sep 2. doi: 10.1002/cam4.1757. [Epub ahead of print]
Source | Full text | Similar articles



.

Patel NV, Schneider JR, Kwan K, Boockvar JA.
The Glioblastoma Cell Ecosystem: Signals Between Progenitors and Progeny.
Neurosurgery. 2018 Sep 1;83(3):E95. doi: 10.1093/neuros/nyy296.
Comment on: Wang X et al, Reciprocal Signaling between Glioblastoma Stem Cells and Differentiated Tumor Cells Promotes Malignant Progression. (Cell Stem Cell. 2018 Apr 5)
Source | Full text | Similar articles



.

Ralff MD, Lulla AR, Wagner J, El-Deiry WS.
ONC201: a new treatment option being tested clinically for recurrent glioblastoma.
Transl Cancer Res. 2017 Oct;6(Suppl 7):S1239-S1243. doi: 10.21037/tcr.2017.10.03.
Comment on: Arrillaga-Romany I, Chi AS, Allen JE, et al. A phase 2 study of the first imipridone ONC201, a selective DRD2 antagonist for oncology, administered every three weeks in recurrent glioblastoma. Oncotarget 2017;8:79298-304
Source | Full text | Similar articles



.

Schijns VEJC, Pretto C, Strik AM, Gloudemans-Rijkers R, Deviller L, Pierre D, Chung J, Dandekar M, Carrillo JA, Kong XT, Fu BD, Hsu FPK, Hofman FM, Chen TC, Zidovetzki R, Bota DA, Stathopoulos A.
Therapeutic Immunization against Glioblastoma.
Int J Mol Sci. 2018 Aug 27;19(9). pii: E2540. doi: 10.3390/ijms19092540.
Source | Full text | Similar articles



.

Sestito S, Runfola M, Tonelli M, Chiellini G, Rapposelli S.
New Multitarget Approaches in the War Against Glioblastoma: A Mini-Perspective.
Front Pharmacol. 2018 Aug 3;9:874. doi: 10.3389/fphar.2018.00874. eCollection 2018.
Source | Full text | Similar articles



.

Taiwo R, Mahlokozera T, Kim AH.
Stem nourished by branches: glioblastomas co-opt classic neurotrophic factor signaling to maintain stem-like cell pool.
Stem Cell Investig. 2018 Jul 23;5:22. doi: 10.21037/sci.2018.07.01. eCollection 2018.
Comment on: Wang X et al, Reciprocal Signaling between Glioblastoma Stem Cells and Differentiated Tumor Cells Promotes Malignant Progression. (Cell Stem Cell. 2018 Apr 5)
Source | Full text | Similar articles



.

Taylor MA, Das BC, Ray SK.
Targeting autophagy for combating chemoresistance and radioresistance in glioblastoma.
Apoptosis. 2018 Aug 31. doi: 10.1007/s10495-018-1480-9. [Epub ahead of print]
Source | Full text | Similar articles



.

Taylor JW, Parikh M, Phillips JJ, James CD, Molinaro AM, Butowski NA, Clarke JL, Oberheim-Bush NA, Chang SM, Berger MS, Prados M.
Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma.
J Neurooncol. 2018 Aug 27. doi: 10.1007/s11060-018-2977-3. [Epub ahead of print]
Source | Full text | Similar articles



.

Wang X, Prager BC, Wu Q, Kim LJY, Gimple RC, Shi Y, Yang K, Morton AR, Zhou W, Zhu Z, Obara EAA, Miller TE, Song A, Lai S, Hubert CG, Jin X, Huang Z, Fang X, Dixit D, Tao W, Zhai K, Chen C, Dong Z, Zhang G, Dombrowski SM, Hamerlik P, Mack SC, Bao S, Rich JN.
Reciprocal Signaling between Glioblastoma Stem Cells and Differentiated Tumor Cells Promotes Malignant Progression.
Cell Stem Cell. 2018 Apr 5;22(4):514-528.e5. doi: 10.1016/j.stem.2018.03.011.
Source | Full text | Similar articles



EMBRYONAL TUMORS

.

Cohen KJ, Constine LS, Packer RJ, Smith MA.
Childhood Central Nervous System Embryonal Tumors Treatment (PDQ®): Health Professional Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2018 Aug 17.
Source | Table of contents | Book | Similar articles



LYMPHOMAS

.

Chamoun K, Choquet S, Boyle E, Houillier C, Larrieu-Ciron D, Al Jijakli A, Delrieu V, Delwail V, Morschhauser F, Hoang-Xuan K, Soussain C.
Ibrutinib monotherapy in relapsed/refractory CNS lymphoma: A retrospective case series.
Neurology. 2017 Jan 3;88(1):101-102. doi: 10.1212/WNL.0000000000003420. Epub 2016 Nov 18.
Source | Full text | Similar articles



METASTATIC TUMORS

.

Kennion O, Holliman D.
Outcome after craniotomy for recurrent cranial metastases.
Br J Neurosurg. 2017 Jun;31(3):369-373. doi: 10.1080/02688697.2017.1302072. Epub 2017 Mar 14.
Source | Full text | Similar articles



.

Press RH, Zhang C, Cassidy RJ, Ferris MJ, Zhong J, Steuer CE, Pillai RN, Owonikoko TK, Kahn S, Ramalingam SS, Patel PR, Curran WJ, Shu HG, Sica GL, Higgins KA.
Targeted Sequencing and Intracranial Outcomes of Patients With Lung Adenocarcinoma Brain Metastases Treated With Radiotherapy.
Cancer. 2018 Aug 18. doi: 10.1002/cncr.31589. [Epub ahead of print]
Source | Full text | Similar articles



.

Rice SR, Bentzen SM, Hanna A, Choi E, Boggs DH, Kwok Y, Hyder J, Feigenberg SJ, Regine WF, Woodworth GF, Eisenberg HM, Yu C, Biggins TF, Barnholtz-Sloan JS, Sperduto PW, Weltman E, Mehta MP.
Prognostic models for patients with brain metastases after stereotactic radiosurgery with or without whole brain radiotherapy: a validation study.
J Neurooncol. 2018 Aug 21. doi: 10.1007/s11060-018-2958-6. [Epub ahead of print]
Source | Full text | Similar articles



.

Witzel I, Laakmann E, Weide R, Neunhöffer T, Park-Simon TJ, Schmidt M, Fasching PA, Hesse T, Polasik A, Mohrmann S, Würschmidt F, Schem C, Bechtner C, Würstlein R, Fehm T, Möbus V, Burchardi N, Loibl S, Müller V.
Treatment and outcomes of patients in the Brain Metastases in Breast Cancer Network Registry.
Eur J Cancer. 2018 Aug 9;102:1-9. doi: 10.1016/j.ejca.2018.07.004. [Epub ahead of print]
Source | Full text | Similar articles